AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“AfroCentric”) Dealing in Securities by the Company Secretary and a Director of a Major Subsidiary In compliance with the terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the Company hereby discloses the following director’s dealings in AfroCentric shares relating to options or shares accepted in terms of the Company’s Share Option Scheme: Name of Director Aklaaq Mahmood Designation: Executive Director of Medscheme, a major subsidiary of AfroCentric Date of transaction: 20 December 2023 Nature of transaction: On market disposal of Afrocentric shares Class of securities: Ordinary shares Number of securities: 300 000 Price per security: R3.00 Value of transaction: R900 000 Nature of interest: Direct Beneficial Clearance obtained: Yes Name of Director Mr DR Mokale Designation: Company Secretary Date of transaction: 20 December 2023 Nature of transaction: On market disposal of Afrocentric shares Class of securities: Ordinary shares Number of securities: 106 667 Price per security: R3.00 Value of transaction: R320 001 Nature of interest: Direct Beneficial Clearance obtained: Yes Johannesburg 21 December 2023 JSE Sponsor to AfroCentric Questco Corporate Advisory Proprietary Limited